FGK Clinical Research Signs Five-Year Agreement with OmniComm Systems

FGK Clinical Research GmbH (FGK) has entered into a multi-year partnership with OmniComm Systems. Under the terms of the agreement, FGK will use TrialMaster® electronic data capture (EDC), IRTMaster (web-based self-service clinical supply management and randomization), and Acuity Analytics (data visualization and risk-based monitoring) along with other related products/services to supplement FGK’s clinical trial operational and data management services to pharmaceutical, biotechnology and medical device companies.

“It’s very rewarding for OmniComm to be able to deliver a myriad of fully integrated eClinical solutions that align perfectly with our client’s needs,” said Stephen Johnson, chief revenue officer of OmniComm. “We look forward to a rapid adoption and working together with FGK to simplify the clinical research process for their clients.”

The Munich based company selected OmniComm’s technology suite for its user-friendly interface and streamlined user management, with the added benefit of seamless data integration across the EDC and IRT systems, eliminating redundancy in data entry and improving efficiency for investigative sites. The implementation and onboarding process will be managed locally, and all training will be delivered by OmniComm’s expert professional services group based out of its German office in Bonn.

“It is an important step for FGK to strengthen our abilities in clinical trials with the eSolutions of OmniComm. FGK has very challenging projects and OmniComm’s products perfectly fit to our strategy to apply best solutions on latest technology,” said Managing Director Martin Krauss. “We look forward to the partnership with OmniComm for the benefit of our Client’s projects.”

  • <<
  • >>

Join the Discussion